You are here: Home > News & Events > News

IDIBAPS hosts the meeting of the HEP-CAR european project on hepatocarcinoma and co-morbidities.

07/04/2017

On 13 March, IDIBAPS hosted the annual meeting of the European HEP-CAR consortium. The aim of the project is to identify the molecular mechanisms involved in the development of hepatocellular carcinoma (HCC) and their role in the different co-morbidities that induce the onset of this type of cancer: the infection by hepatitis B and C viruses, alcohol intake or obesity. 

Read more about "IDIBAPS hosts the meeting of the HEP-CAR european project on hepatocarcinoma and co-morbidities."

The ‘Handbook of Translational Medicine’ is available now

The ‘Handbook of Translational Medicine’ is available now. Edited by Prof Josep M Llovet in collaboration with other teachers from the official Master in Translational Medicine (University of Barcelona).

Read more about "The ‘Handbook of Translational Medicine’ is available now"

Prof Llovet has been elected Vice-Chair of the AASLD Hepatobiliary Neoplasia SIG.

 Prof Llovet has been elected Vice-Chair of the AASLD Hepatobiliary Neoplasia SIG. His 2 year term will begin on January 1st, 2017 until December 31st, 2018 and then he will move into the Chair role for 2 years beginning January 1st, 2019 until December 31st, 2020. 

IDIBAPS researchers identify a new therapeutic target for liver cancer

IDIBAPS researchers have identified the first epi-driver in liver cancer, a type of epigenetic alteration in the IGF2 gene that causes tumors to grow.

In the study, published in the Gastroenterology journal, they have found that this alteration occurs in 15% of tumors and that a monoclonal antibody can effectively block it and slow tumor progression in animal models. Dr. Josep M. Llovet, ICREA Professor, Head of the Translational research in hepatic oncology IDIBAPS group and Director of the Mount Sinai Liver Cancer Program at Icahn School of Medicine at Mount Sinai (New York), has coordinated this study. The first authors of the article are Iris Martínez-Quetglas and Roser Pinyol, researchers at the same team.

Read more about "IDIBAPS researchers identify a new therapeutic target for liver cancer"

Four researchers at Hospital Clínic and IDIBAPS among the 2015 most cited scientists

Thomson Reuters lists the 3000 most important names of 21 fields in science and social sciences. There have been evaluated articles published in indexed journals in these fields between 2003 and 2013 and there have only been considered those that rank in the top 1% by citations for field and year indexed in the Web of Science, the so called Highly Cited Papers. Thus, the fact of belonging to this classification means that the work of these researchers is considered particularly important among his colleagues.

Read more about "Four researchers at Hospital Clínic and IDIBAPS among the 2015 most cited scientists"

IDIBAPS participates in a 5.7M European project to improve knowledge on liver cancer

September 2015

The Translational Reserarch in Hepatic Oncology IDIBAPS group, led by Dr. Josep M. Llovet, in collaboration with Dr. Roser Pinyol and 8 more researchers, participates in a European project to identify the molecular mechanisms that have a direct impact on the development of hepatocellular carcinoma (HCC). The HEP-CAR project will evaluate the role of these mechanisms in different liver diseases leading to HCC -the infection by hepatitis B and C, overweight or alcohol-. This research initiative, coordinated by the University of Freiburg and in which ten European academic centers are involved, is part of Horizon 2020, the European Comission framework programme for research and innovation, and it is endowed with a budget of 5.7 million euros, one of them corresponding to IDIBAPS.

Read more about "IDIBAPS participates in a 5.7M European project to improve knowledge on liver cancer"

A pioneering study correlates genetic alterations and environmental factors in liver cancer

March 2015

IDIBAPS researchers have participated in a pioneering study in hepatocellular carcinoma, the most common liver cancer, in which all the genetic alterations that occur in this type of tumor have been characterized. In an article published in the journal Nature Genetics scientists provide a complete overview of the disease and these genetic alterations associated with the etiology and clinical characteristics, the proposed treatments for patients approved for other cancers, which could be applied in each case. Dr. Josep Maria Llovet, ICREA professor at the IDIBAPS Hepatic Oncology Group and director of the Liver Cancer Program at the Icahn School of Medicine at Mount Sinai (New York), and Dr. Roser Pinyol, researcher at the same group, have participated in this article led by Dr. Jessica Zucman-Rossi, from the INSERM-Paris. 

Read more about "A pioneering study correlates genetic alterations and environmental factors in liver cancer"

First step to treat one of the most aggressive hepatic cancers.

Primer paso para tratar uno de los cánceres hepáticos más agresivos

05/02/2013

El colangiocarcinoma hepático, una de las clases de cáncer de hígado más agresiva, ya no es un tumor desconocido. Un grupo de investigadores de 16 profesionales del Instituto de Investigaciones Biomédicas Pi i Sunyer, centro adscrito al hospital Clínic en Barcelona, han establecido su composición molecular.

Read more about "First step to treat one of the most aggressive hepatic cancers."

Five researchers from IDIBAPS among the most cited scientists

26/06/2014

Thomson Reuters has published the list of the Highly Cited Researchers, a compilation of the most influential names in science. 50 Spanish researchers from different broad fields of sciences and social sciences appear on the list. In the field of Clinical Medicine, four of the seven Spanish investigators listed are researchers from IDIBAPS. The health research institute associated to Hospital Clínic and Universitat de Barcelona also has the only Spanish researcher in Psychiatry.

Read more about "Five researchers from IDIBAPS among the most cited scientists"

IDIBAPS participates in 10 of the 50 most influential works of the last 10 years with Spanish participation

11/04/2013

DIBAPS participates in 10 of the 50 most influential works of the last 10 years with Spanish participation The Centre for Research Survey of the Institute of Catalan Studies (Observatori de la Recerca de l’Institut d’Estudis Catalans)publishes almost half of the most cited researchers in Spain work in Catalonia. IDIBAPS is, with 10 articles, the Catalan center which appears in a greater number of jobs among the 50 most cited papers with Spanish participation. These data confirm once again the significance of Catalan research and IDIBAPS, Hospital Clinic of Barcelona Faculty of Medicine and University of Barcelona leadership. The data were extracted from Thomson Reuters Essential Science Indicators database, which determines from bibliometric data the influence of researchers, institutions, documents, publications, scientific fields and emerging research areas in 22 countries. Among the 50 documents participated by institutions in Spain collecting a greater number of citations, 36 (72%) have at least one author from geographical areas of Catalan language and culture. In addition, 47.4% of the 78 Spanish researchers involved work in scientific institutions in Catalonia.

Read more about "IDIBAPS participates in 10 of the 50 most influential works of the last 10 years with Spanish participation"

Project led by: Idibaps

Copyright © 2010 - 2017 HEPTROMIC

HEPTROMIC is a project in the 'Health' Theme of the Specific Programme 'Cooperation' of the European Commission's Seventh Framework Programme.